The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects
Pharmacogenomics and Personalized Medicine · 2021-04 · Volume 14 · 477-485
DOI: 10.2147/pgpm.s291723 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pharmacogenomics and Personalized Medicine, 2021-04. Verfasst von Yue Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Center, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Key Laboratory of…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Trial Center, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Beijing Ho…
- Internal Medicine-Cardiovascular Department, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing Hospital, Beijing, People's Republic of China.
ORCID-Profile: Zuowei Pei
Zitieren
APA
Liu, Y., Yang, C., Qi, W., Pei, Z., Xue, W., Zhu, H., Dong, M., Guo, Y., Cong, D., & Wang, F. (2021). The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects. Pharmacogenomics and Personalized Medicine, Volume 14, 477-485. https://doi.org/10.2147/pgpm.s291723
Vancouver
Liu Y, Yang C, Qi W, Pei Z, Xue W, Zhu H, et al. The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects. Pharmacogenomics and Personalized Medicine. 2021;Volume 14:477-485. doi:10.2147/pgpm.s291723
BibTeX
@article{Liu2021,
author = {Liu, Yue and Yang, Chenguang and Qi, Wenyuan and Pei, Zuowei and Xue, Wei and Zhu, Huolan and Dong, Min and Guo, Ying and Cong, Duanduan and Wang, Fang},
title = {The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects},
journal = {Pharmacogenomics and Personalized Medicine},
year = {2021},
volume = {Volume 14},
pages = {477--485},
doi = {10.2147/pgpm.s291723}
}
EUVIMED